In gastric cancer, higher levels of NPAS2 protein expression were positively correlated with venous and lymphatic vessel invasion, primary and loco-regional lymph node involvement, the presence of distant metastasis and a higher stage of tumor–node–metastasis classification, predicting a worse prognosis and reduced three-year overall survival rates [127]. The gene discussed is NPAS2; the disease is gastric cancer.